Jackson Acquisition Co II
JACS_u10.500USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Jackson Acquisition Co II Company
Jackson Acquisition Company II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business by concentrating its efforts in identifying businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry. The Company neither engaged in any operations nor generated any revenue.
Jackson Acquisition Co II Info
Ticker SymbolJACS_u
Company nameJackson Acquisition Co II
IPO dateDec 10, 2024
CEOJackson (Richard L)
Number of employees- -
Security typeUnit
Fiscal year-end- -
Address2655 Northwinds Parkway
CityALPHARETTA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30009
Phone17706435605
Websitehttps://jacksonacquisitions.com/home/default.aspx
Ticker SymbolJACS_u
IPO dateDec 10, 2024
CEOJackson (Richard L)
Company Executives of Jackson Acquisition Co II
Name
Name/Position
Position
Shareholding
Change
Mr. Brian A. Mccarthy
Mr. Brian A. Mccarthy
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Stephan S. Rodgers
Mr. Stephan S. Rodgers
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Richard L. (Rick) Jackson
Mr. Richard L. (Rick) Jackson
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. David Lawrence
Mr. David Lawrence
Chief Financial Officer
Chief Financial Officer
--
--
Mr. J. Nicholas Ayers
Mr. J. Nicholas Ayers
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Paul G. Gabos
Mr. Paul G. Gabos
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Brian A. Mccarthy
Mr. Brian A. Mccarthy
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Stephan S. Rodgers
Mr. Stephan S. Rodgers
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Richard L. (Rick) Jackson
Mr. Richard L. (Rick) Jackson
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. David Lawrence
Mr. David Lawrence
Chief Financial Officer
Chief Financial Officer
--
--
Mr. J. Nicholas Ayers
Mr. J. Nicholas Ayers
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Paul G. Gabos
Mr. Paul G. Gabos
Independent Director Nominee
Independent Director Nominee
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Calamos Advisors LLC
2.17%
RJ Healthcare SPAC II LLC
2.15%
AQR Arbitrage, LLC
0.22%
Clear Street LLC
0.05%
Clear Street Group Inc
0.04%
Other
95.36%
Shareholders
Shareholders
Proportion
Calamos Advisors LLC
2.17%
RJ Healthcare SPAC II LLC
2.15%
AQR Arbitrage, LLC
0.22%
Clear Street LLC
0.05%
Clear Street Group Inc
0.04%
Other
95.36%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
2.39%
Corporation
2.15%
Research Firm
0.05%
Investment Advisor
0.04%
Other
95.36%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
46
962.53K
4.18%
-20.29M
2025Q2
47
5.85M
25.45%
-14.79M
2025Q1
46
5.80M
25.23%
-14.84M
2024Q4
44
21.10M
91.74%
+21.10M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Calamos Advisors LLC
500.00K
2.17%
--
--
Jun 30, 2025
RJ Healthcare SPAC II LLC
495.00K
2.15%
+495.00K
--
Dec 31, 2024
AQR Arbitrage, LLC
50.23K
0.22%
-360.21K
-87.76%
Mar 31, 2025
Clear Street LLC
12.31K
0.05%
+6.83K
+124.69%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
CrossingBridge Pre-Merger SPAC ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
Proportion0%
RiverNorth Enhanced Pre-Merger SPAC ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Jackson Acquisition Co II?
The top five shareholders of Jackson Acquisition Co II are:
Calamos Advisors LLC holds 500.00K shares, accounting for 2.17% of the total shares.
RJ Healthcare SPAC II LLC holds 495.00K shares, accounting for 2.15% of the total shares.
AQR Arbitrage, LLC holds 50.23K shares, accounting for 0.22% of the total shares.
Clear Street LLC holds 12.31K shares, accounting for 0.05% of the total shares.
Calamos Advisors LLC holds 500.00K shares, accounting for 2.17% of the total shares.
RJ Healthcare SPAC II LLC holds 495.00K shares, accounting for 2.15% of the total shares.
AQR Arbitrage, LLC holds 50.23K shares, accounting for 0.22% of the total shares.
Clear Street LLC holds 12.31K shares, accounting for 0.05% of the total shares.
What are the top three shareholder types of Jackson Acquisition Co II?
The top three shareholder types of Jackson Acquisition Co II are:
Calamos Advisors LLC
RJ Healthcare SPAC II LLC
AQR Arbitrage, LLC
Calamos Advisors LLC
RJ Healthcare SPAC II LLC
AQR Arbitrage, LLC
How many institutions hold shares of Jackson Acquisition Co II (JACS_u)?
As of 2025Q3, 46 institutions hold shares of Jackson Acquisition Co II, with a combined market value of approximately 962.53K, accounting for 4.18% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -21.26%.
What is the biggest source of revenue for Jackson Acquisition Co II?
In --, the -- business generated the highest revenue for Jackson Acquisition Co II, amounting to -- and accounting for --% of total revenue.
